According to The Financial Express, the analysis screened SME companies with market capitalisation above ₹100 crore and return on capital employed (ROCE) exceeding 15%. The companies required three-year average ROCE above 15%, three-year annualised sales and profit growth above 10% each, operating margins exceeding 10%, and debt-to-equity ratio below 0.5. Additionally, operating cash flow had to be positive in the latest financial year, debtor days remained below 150, and the companies needed more than 100 shareholders with promoter ownership exceeding 30% and no pledged promoter shares.
As reported by The Financial Express, Canarys Automations promoter holding rose from 56.62% in March 2025 to 58.16% in March 2026, driven by the April 2025 acquisition of a 51% stake in US-based Fortira. The company's three-year sales and profit CAGRs stood at 39% and 17% respectively, with ROCE at 22.6%. FY26 consolidated revenue increased 122.4% year-on-year to ₹198.1 crore, while net profit attributable to shareholders grew 48.6% to ₹12.32 crore. The company's order book stands at approximately ₹441 crore with most projects spanning three years.
According to The Financial Express, Gayatri Rubbers and Chemicals promoter holding reached 74.03% in March 2026, rising from 73.56% in September 2025. The company's three-year sales and profit CAGRs of 23% and 83% respectively support its inclusion, with ROCE at 37.9%. FY26 operating revenue rose 31% year-on-year to ₹41.8 crore, while net profit increased 96% to ₹5.6 crore. The company secured a ₹1.2 crore BEML gasket order and expects Plant 2 utilisation to rise from 30% to 70-80% over 18-24 months.
As reported by The Financial Express, Systango Technologies promoter holding edged up to 72.17% in March 2026 from 71.96% in March 2023, with modest increases of 0.21 percentage points. The company's three-year sales and profit CAGRs of 20% and 32% respectively support its selection, with operating margins at approximately 38% and ROCE at 33%. FY26 consolidated operating revenue rose 34.6% year-on-year to ₹90.4 crore, while net profit increased 34.3% to ₹31.9 crore. The company has secured an Alibaba Cloud alliance and targets AI and cloud services expansion in the US, UK and Europe.
According to The Financial Express, Chandan Healthcare promoter holding rose to 49.61% in June 2026 from 49.43% in March 2025, with the company targeting 1,000 franchises by March 2027 against 264 in June 2026. The company's three-year sales and profit CAGRs of 26% and 79% respectively support its selection. Q1 FY27 consolidated income rose 19.6% year-on-year to ₹82.3 crore, while net profit attributable to shareholders increased 29.5% to ₹7.5 crore. The company announced the sale of its 53.56% stake in Chandan Pharmacy for ₹16.77 crore to fund diagnostics expansion.
